Ca2+ sensor-mediated ROS scavenging suppresses rice immunity and is exploited by a fungal effector M Gao, Y He, X Yin, X Zhong, B Yan, Y Wu, J Chen, X Li, K Zhai, Y Huang, ... Cell 184 (21), 5391-5404. e17, 2021 | 143 | 2021 |
Properdin: A multifaceted molecule involved in inflammation and diseases JY Chen, C Cortes, VP Ferreira Molecular immunology 102, 58-72, 2018 | 72 | 2018 |
Properdin is a key player in lysis of red blood cells and complement activation on endothelial cells in hemolytic anemias caused by complement dysregulation JY Chen, NS Galwankar, HN Emch, SS Menon, C Cortes, JM Thurman, ... Frontiers in immunology 11, 1460, 2020 | 15 | 2020 |
A privacy-aware distributed knowledge graph approach to qois-driven covid-19 misinformation detection L Shang, Z Kou, Y Zhang, J Chen, D Wang 2022 IEEE/ACM 30th International Symposium on Quality of Service (IWQoS), 1-10, 2022 | 5 | 2022 |
Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria L Zhang, JY Chen, C Kerr, BA Cobb, JP Maciejewski, F Lin Leukemia 35 (4), 1176-1187, 2021 | 5 | 2021 |
The role of properdin and Factor H in disease C Cortes, C Desler, A Mazzoli, JY Chen, VP Ferreira Advances in Immunology 153, 1-90, 2022 | 4 | 2022 |
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell–mediated disorders L Zhang, L Luo, JY Chen, R Singh, WM Baldwin III, DA Fox, DJ Lindner, ... JCI insight 8 (23), 2023 | 2 | 2023 |
Complement Receptor C3aR1 Contributes to Paclitaxel-Induced Peripheral Neuropathic Pain in Mice and Rats J Xu, P Huang, B Bie, Y Dai, S Ben-Salem, N Borjini, L Zhang, J Chen, ... The Journal of Immunology 211 (11), 1736-1746, 2023 | 1 | 2023 |
A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia JY Chen, L Zhang, L Luo, M Yang, Y Chen, F Lin Clinical Immunology 253, 109678, 2023 | 1 | 2023 |
Humanization of a mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases L Zhang, K Armour, JY Chen, A Mylona, M Yang, GR Andersen, ... Molecular immunology 170, 19-25, 2024 | | 2024 |
Development of a C3 humanized rat as a new model for evaluating novel C3 inhibitors JY Chen, L Zhang, M Yang, ED Hughes, ZT Freeman, TL Saunders, F Lin Journal of Innate Immunity 16 (1), 56-65, 2023 | | 2023 |
8 Humanization of the mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases L Zhang, K Armour, J Chen, A Mylona, M Yang, H Olesen, G Andersen, ... Immunobiology 228 (5), 152467, 2023 | | 2023 |
Development of a complement C3 humanized rat as a new model for evaluating novel C3 inhibitors F Lin, L Zhang, M Yang, E Hughes, T Saunders, J Chen Investigative Ophthalmology & Visual Science 64 (8), 2725-2725, 2023 | | 2023 |
Locally produced complement C1q regulates corneal epithelium wound healing JY Chen, Y Sun, C Tam, F Lin Investigative Ophthalmology & Visual Science 64 (8), 1880-1880, 2023 | | 2023 |